Investment
Features
FeesSafety
Academy
More
Pluang+

Compare KB Financial Group, Inc. (KB) vs State Street SPDR S&P Biotech ETF (XBI) Price & Performance

KB Financial Group, Inc.Trade
State Street SPDR S&P Biotech ETFTrade

Price performance (Past 24H)

Key statistics

KB Financial Group, Inc. vs State Street SPDR S&P Biotech ETF — how do they compare? KB Financial Group, Inc. trades at $117.53 (market cap $41.21B), while State Street SPDR S&P Biotech ETF trades at $158.28. The key difference: KB Financial Group, Inc. pays a 2.67% dividend while State Street SPDR S&P Biotech ETF pays none. Which is the better fit depends on your goals.

KBXBI
Market Cap
$41.21B
Sector
FinancialsBroad Market / Factor
52-Week High
$124.01$164.28
52-Week Low
$77.50$86.92
Dividend Yield
2.67%

Returns comparison

Trailing returns across standard periods

About KB Financial Group, Inc.

KB Financial is the parent company of KB Kookmin Bank, Korea's largest commercial bank, with a 13.1% share of loans as of 2021. Its predecessor banks were established in the 1960s as government policy banks and privatized in the 1990s. Its credit card subsidiary KB Kookmin Card is the number-three player behind Shinhan Card and Samsung Card. KB has in recent years expanded its nonbank business by buying LIG Insurance and Hyundai Securities, making KB a top-five player in nonlife insurance and in securities, and most recently by buying Prudential Life Insurance Korea. It also has KB Capital, which provides leasing and installment finance.

Read more on KB

About State Street SPDR S&P Biotech ETF

XBI is an equal-weighted ETF that tracks the U.S. biotechnology segment. It provides diversified exposure to small, mid, and large-cap biotech firms involved in drug discovery and medical research, such as Moderna and Exact Sciences.

Read more on XBI